EP3302550
Samsetning af and-CD19 mótefni og Brutons týrósínkínasahemli og notkun hennar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.5.2016EP published:
28.8.2019EP application number:
16725504.1
EP translation filed:
29.10.2019Grant published:
15.11.2019EPO information:
European Patent Register
Max expiry date:
24.5.2036Expiry date:
24.5.2026Next due date:
31.5.2026
Title:
COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON'S TYROSINE KINASE INHIBITOR AND USES THEREOF
Timeline
Today
25.5.2016EP application
28.8.2019EP Publication
29.10.2019Translation submitted
15.11.2019Registration published
24.5.2026Expires
Owner
Name:
Incyte CorporationAddress:
1801 Augustine Cut-Off, Wilmington, Delaware 19803, US
Inventor
Name:
ENDELL, JanAddress:
München, DE
Name:
BOXHAMMER, RainerAddress:
Kolbermoor, DE
Name:
WINDERLICH, MarkAddress:
München, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
15169124Date:
26.5.2015Country:
EP
Number:
15196860Date:
27.11.2015Country:
EP
Classification
Categories:
A61K 39/395, A61K 31/519, A61P 35/00, A61K 31/505, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 19.5.2020
Expires: 24.5.2021
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 3.5.2021
Expires: 24.5.2022
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 3.5.2022
Expires: 24.5.2023
Payer: Patice ehf.
Number: 8
Paid: 23.5.2023
Expires: 24.5.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 23.5.2024
Expires: 24.5.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 30.5.2025
Expires: 24.5.2026
Payer: Árnason Faktor ehf.